57
57
42
42
57
57
57
57
57
Cyberattack causes network outage at Boston Scientific, disrupts global operations
Boston Scientific disclosed a cyberattack that caused a network outage, disrupting global operations including order processing and shipping.
The medical device maker detected the incident on August 25, activated incident response protocols with third-party cybersecurity experts, and told the SEC that access to systems supporting operations, including order processing and shipping, was disrupted. Boston Scientific employs about 59,000 people across 127 countries and posted more than $20 billion in net sales in 2025; it has not determined whether the incident is material and no group has claimed responsibility. The company joins a recent run of medtech attacks including Stryker, iRhythm, Novo Nordisk and Xsolis.
70
57
57
57
57
57
57
57
42
57
Texas Utility CenterPoint Energy Confirms Breach After Hacker Leaks Data
CenterPoint Energy confirmed hackers stole customer personal data from an external-facing system after a forum leak of 7.5 million records.
CenterPoint Energy, a Houston-based utility serving roughly 7 million customers across Indiana, Minnesota, Ohio and Texas, told the SEC that an unauthorized third party obtained customer personal information through an external-facing system. On September 12 a hacker claimed to have stolen nearly 7.5 million records and posted a 2.5 GB archive on a cybercrime forum, threatening to attack main infrastructure next. The company says electric and gas delivery is unaffected and it expects no material impact. Earlier 2024 leak claims were attributed to Cl0p's 2023 MOVEit campaign via a third party.
76
Boston Scientific left nursing its bottom line after cyberattack
Boston Scientific says its August 25 network intrusion will materially hit third-quarter and full-year sales and earnings, likely missing guidance.
Boston Scientific detected unauthorized activity on its network on August 25 and took systems offline, disrupting order processing and shipping operations worldwide. In an SEC filing, the medical device maker warned of a material impact on Q3 and full-year results, making it unlikely to meet the net sales growth and adjusted EPS guidance issued in July. Its distribution network has been substantially restored, sterilization facilities are operational, manufacturing resumed at most sites, and an interruption affecting cardiac device remote-monitoring activations was resolved. The company has not revealed the attack vector, whether ransomware was involved, or whether data was stolen; no ransomware group has claimed responsibility and the investigation continues.
74
57
57
57
57
42
57
57
57
57
57
57
57
57
57
57
57
57
57
42